Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2100
Title: A randomised control trial to evaluate the role/efficacy of Single dose intravenous tranexamic acid at the time of Induction of anaesthesia for postoperative seroma formation In paraumbilical hernioplasty at a tertiary care centre from 1st september 2023 to 31st august 2024
Authors: REG.NO:BH0122013
Keywords: Paraumbilical hernia, tranexamic acid, seroma, surgical site infection.
Issue Date: 2025
Publisher: KLE Academy of Higher Education and Research, Belagavi
Abstract: ABSTRACT Title: A randomised control trial to evaluate the role/efficacy of single dose intravenous tranexamic acid at the time of induction of anaesthesia for postoperative seroma formation in paraumbilical hernioplasty at a tertiary care centre from 1 st September 2023 to 31 st August 2024 Background: Paraumbilical hernia is a prevalent surgical procedure, and advancement in using newer pharmacologic agents such as Tranexamic acid (TXA) aim to optimize patient outcomes by reducing seroma formation, surgical site infections and related complications. This study aims to compare the outcomes of two groups one of which received intravenous tranexamic acid and its effect on drain output. Aim: To evaluate the efficacy of intravenous Tranexamic acid (TXA) at the time of induction of anaesthesia in reducing post-operative seroma formation after para- umbilical hernioplasty Settings: Kle’s Dr. Prabhakar Kore hospital and Medical Research Centre, Belagavi, Karnataka
URI: http://localhost:8080/xmlui/handle/123456789/2100
Appears in Collections:General Surgery MS

Files in This Item:
File Description SizeFormat 
BH0122013.pdf3.72 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.